His translational research has focused on mesothelioma with several important studies investigating antibody drug conjugates, antiapoptotics and more recently genomic diversity and circulating tumour DNA in this disease.He is on faculty for the lung tumour track for the European Society of Medical Oncology, an associate editor for the Journal of Thoracic Oncology and chair the Scientific committee for the Thoracic Oncology Group of Australasia.